SJS Investment Consulting’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBRX
SJS Investment Consulting's IBRX Position: Q3 2026 in Review
SJS Investment Consulting held its ImmunityBio (IBRX) position steady in Q3 2026 at 118 shares worth $1.11K. The position accounts for ﹤0.01% of the portfolio, ranked #2456.
SJS Investment Consulting first reported a position in IBRX in Q1 2022 and has held it in 12 quarters since. 407 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.
- SJS Investment Consulting held 118 shares of ImmunityBio worth $1.11K as of Q3 2026.
- SJS Investment Consulting left its ImmunityBio share count unchanged in Q3 2026.
- ImmunityBio made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #2456 holding.
- SJS Investment Consulting first reported a position in ImmunityBio in Q1 2022 and has held it in 12 quarters since.
- 407 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.
Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.